Erdafitinib - Janssen Pharmaceutica
At a glance
- Drug Originator Astex Therapeutics; Newcastle University
- Drug Licenced by Janssen Pharmaceutica
- Drug Class Antineoplastics; Diamines; Pyrazoles; Quinoxalines; Small molecules
- Mechanism of Action Fibroblast growth factor receptor antagonists
- USA Patent Applicants JANSSEN BIOTECH
- USA Patents 11
- NDAs 1
- International Patents 294
- Patent Applications 188
Disclaimer